Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 44.15
+0.40 (0.91%)
Feb 11, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.83 billion as of February 13, 2026. Its market cap has decreased by -6.36% in one year.
Market Cap
3.83B
Enterprise Value
5.66B
Revenue
4.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
44.15
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.83B, an increase of 446.49%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.83B | -1.45% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 6.82B |
| Orient Pharma | 6.49B |
| SCI Pharmtech | 6.21B |
| Easywell Biomedicals | 4.08B |
| Merdury Biopharmaceutical | 3.58B |
| Maywufa Company | 2.92B |
| PhytoHealth | 2.89B |
| Golden Biotechnology | 2.71B |